Freeline Therapeutics Holdings plc Quarterly Preferred Stock, Par or Stated Value Per Share in USD/shares from Q4 2018 to Q4 2022

Taxonomy & unit
us-gaap: GBP/shares and USD/shares
Description
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Summary
Freeline Therapeutics Holdings plc quarterly Preferred Stock, Par or Stated Value Per Share history and growth rate from Q4 2018 to Q4 2022.
  • Freeline Therapeutics Holdings plc Preferred Stock, Par or Stated Value Per Share for the quarter ending December 31, 2022 was 0 USD/shares, unchanged year-over-year.
Preferred Stock, Par or Stated Value Per Share, Quarterly (USD/shares)
Preferred Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $0 $0 0% Dec 31, 2022 20-F 2023-04-04
Q4 2021 $0 $0 0% Dec 31, 2021 20-F 2023-04-04
Q3 2021 $0 $0 0% Sep 30, 2021 6-K 2021-11-09
Q2 2021 $0 $0 0% Jun 30, 2021 6-K 2021-08-16
Q1 2021 $0 $0 0% Mar 31, 2021 6-K 2021-05-17
Q4 2020 $0 Dec 31, 2020 20-F 2023-04-04
Q3 2020 $0 Sep 30, 2020 6-K 2021-11-09
Q2 2020 $0 Jun 30, 2020 6-K 2021-08-16
Q1 2020 $0 Mar 31, 2020 6-K 2021-05-17
Q4 2018 $0 Dec 31, 2018 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.